CN106721834A - A kind of solid beverage for improving women's health problem - Google Patents
A kind of solid beverage for improving women's health problem Download PDFInfo
- Publication number
- CN106721834A CN106721834A CN201510822170.2A CN201510822170A CN106721834A CN 106721834 A CN106721834 A CN 106721834A CN 201510822170 A CN201510822170 A CN 201510822170A CN 106721834 A CN106721834 A CN 106721834A
- Authority
- CN
- China
- Prior art keywords
- women
- solid beverage
- health problem
- weight fraction
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 20
- 239000007787 solid Substances 0.000 title claims abstract description 20
- 230000005186 women's health Effects 0.000 title claims abstract description 17
- 239000006041 probiotic Substances 0.000 claims abstract description 15
- 235000018291 probiotics Nutrition 0.000 claims abstract description 15
- 235000020237 cranberry extract Nutrition 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 9
- 230000000529 probiotic effect Effects 0.000 claims abstract description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 5
- 239000000811 xylitol Substances 0.000 claims abstract description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 5
- 229960002675 xylitol Drugs 0.000 claims abstract description 5
- 235000010447 xylitol Nutrition 0.000 claims abstract description 5
- 244000291414 Vaccinium oxycoccus Species 0.000 claims description 9
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 9
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 7
- 235000004634 cranberry Nutrition 0.000 claims description 7
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 3
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 3
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 3
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims description 3
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 3
- 229920002414 procyanidin Polymers 0.000 claims description 3
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 238000011282 treatment Methods 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 5
- 238000011443 conventional therapy Methods 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 238000001815 biotherapy Methods 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000003115 biocidal effect Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000005802 health problem Effects 0.000 description 4
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 3
- 208000037009 Vaginitis bacterial Diseases 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241001468229 Bifidobacterium thermophilum Species 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010023648 Lactase deficiency Diseases 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 241001561398 Lactobacillus jensenii Species 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000019987 cider Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of solid beverage for improving women's health problem, the following active component comprising following weight fraction：Probiotic powder 30-35% and Cranberry extract 4-6%, also including the auxiliary material of following weight fraction：FOS 50%, xylitol 10-12%, microcrystalline cellulose 0.35%.Solid beverage disclosed by the invention uses pure Biotherapy method, coordinates conventional therapy, effectively improves the cure rate of disease treatment, reduces recurrence rate.Simultaneously with a kind of state of organic growth, body health is maintained after disease cured, allow women to break away from the puzzlement of various women's diseases, improve the quality of women's health life.
Description
Technical field
The present invention relates to a kind of health beverages, more particularly to a kind of solid beverage that can improve women's health problem.
Background technology
So far, the probiotics that scientist has found generally is divided into three major types, including：1. lactobacillus class is (such as thermophilic
Lactobacillus lactis, Lactobacillus casei, Lactobacillus Jensenii, Raman lactobacillus etc.)；2. Bifidobacterium class (such as bifidobacterium longum, short double
Discrimination bacillus, avette Bifidobacterium, bifidobacterium thermophilum etc.)；3. gram-positive cocci (such as streptococcus fecalis, galactococcus, intermediary
Streptococcus etc.).Additionally, also some saccharomycete can also be included into the category of probiotics with enzyme.
The effect of probiotics may be summarized to be：Prevention improves diarrhoea；Alleviate lactase deficiency shape；Prevention genital system infection；
Enhancing body immunity；Promote enteron aisle digestive system health；Reduce serum cholesterol；Help absorbs nutritional ingredient.
Cranberry, also known as mossberry, cranberry, european cranberry, because the flower of Cranberry is gained the name much like the head and mouth of crane.This is sub-
The species of category are evergreen shrubs, in main growth nice and cool area acid peat soil earth on the Northern Hemisphere.Flower rediance, total shape
Inflorescence.Red fruit can cook fruit and eat.Current some areas in North America are by substantial amounts of plantation.The fruit of results is used for making
Fruit juice, jam etc..Because Cranberry tart flavour in itself is stronger, as in the fruit juice of beverage it is general converted syrup or cider etc. compared with
Sweet composition.Cranberry is a kind of natural antibacterial health fruit, is to prevent and treat the various bacterium infections of the daily urinary system of women, urethra
Inflammation, cystitis, the optimal natural food therapy of chronic nephropyelitis.
Women is often perplexed by problems with：Urinary tract infections；Bacterial vaginosis BV；Vagina infection；Vaginal dysbacteriosis；
Vulvovaginal candidiasis (VVC)；Women particular time body flora maintains (standby pregnant, gestation, postpartum, menopause).
Special health problem related for women in the market, mostly using the method for antibiotic therapy.Although so can be with
Harmful bacteria, but broad-spectrum antibiotic are effectively killed for the lethality non-selectivity of somatic cells, while harmful bacteria is killed
Beneficial bacterium can be in large quantities killed, the ratio and balance of body flora is largely destroyed.Therefore, many women's diseases are answered
Very well, just because body flora is by antibiotic completely after " cleaning ", during reconstruction flora, harmful bacteria is again for hair rate
It is secondary to occupy advantage, so as to trigger new health problem.Long-term use antibiotic, except that can be had undesirable effect to human body itself,
Such as antibiotic associated diarrhea, intestinal bacilli illness, also can aggravate the various problems that female organism occurs in the later stage, cause one kind
Vicious circle.
The content of the invention
In order to solve the above technical problems, the invention provides a kind of solid beverage for improving women's health problem, being improved with reaching
While women's health problem, dysgenic purpose is not produced to human body.
To reach above-mentioned purpose, technical scheme is as follows：
A kind of solid beverage for improving women's health problem, the following active component comprising following weight fraction：Probiotic powder 30-35%
With Cranberry extract 4-6%, also including the auxiliary material of following weight fraction：FOS 50%, xylitol 10-12%, crystallite are fine
Dimension element 0.35%.
Preferably, the following component comprising following weight fraction in the solid beverage：Probiotic powder 33.3%, Cranberry is extracted
Thing 5%, FOS 50%, xylitol 11.35%, microcrystalline cellulose 0.35%.
In such scheme, the total content of Lactobacillus helveticus and Lactobacillus rhamnosus is 15,000,000,000 cfu/g in the probiotic powder.
In such scheme, the weight fraction of the Cranberry extract procyanidins is 4%.
Further technical scheme, the solid beverage be by by the active component and auxiliary material it is well mixed after be packaged to be.
The solid beverage of the improvement women's health problem provided by above-mentioned technical proposal, the present invention is had the following advantages that：
1st, probiotics strain product of the selection with unique effects is combined, and using the synergy between bacterial strain, sets up biological
Barrier, suppresses pathogenic bacteria, maintains the flora ratio of health；
2nd, selection probiotics is combined with Cranberry extract, pure plant and antimicrobial composition, and effect positions that Each performs its own functions, has
Effect ground improves the specific question of women's health.
With beneficial bacterium suppression pathogenic bacteria in itself and the ability being at war with pathogenic bacteria, effectively improve body colony balance simultaneously
A kind of continuable Flora distribution is formed, is coordinated with conventional therapy, the cure rate of disease can be effectively improved, recurrence rate is reduced.
Using probiotics and Cranberry extract thing as functional component in the present invention, through seasoning, preparation after, obtaining having improves female
The food of the special health problem effect of property.The long-term negative effect for controlling special health problem to bring with medicine of women is solved, is changed
Food solution is used, safely and effectively improves women's health.
Specific embodiment
The technical scheme in the embodiment of the present invention will be clearly and completely described below.
The invention provides a kind of solid beverage for improving women's health problem, specific embodiment is as follows：
Embodiment 1：
Active component：Probiotic powder 33.3g and Cranberry extract 5g, Lactobacillus helveticus and Lactobacillus rhamnosus in probiotic powder
Total content be 15,000,000,000 cfu/g, the weight fraction of Cranberry extract procyanidins is 4%；Auxiliary material：FOS 50g,
Xylitol 11.35g, microcrystalline cellulose 0.35g.Solid beverage is packaged to be after above-mentioned active component and auxiliary material are well mixed.
Process of the test：Women of the selection with bacterial vaginosis BV, the product in the cooperation present invention on the premise of conventional therapy,
Investigate the success rate of disease treatment.
Study subject：80 women with bacterial vaginosis BV, receive identical conventional treatments, and treatment process is consistent.
Test method：80 study subjects are divided into two groups, every group of 40 people, one of which when therapeutic test starts, daily
The solid beverage 2g in the present invention is taken, tested group is calculated as；Another group of 1 part of the placebo for daily being made with maltodextrin,
It is calculated as control group.3 to 4 days, 5 to 6 all, tracking of 2 to 4 months are carried out in experiment respectively, two groups of subject bacteriums are investigated
The success rate of vaginosis treatment, concrete outcome such as table 1.
1 different tests time of table cure rate data
| 3-4 days | 5-6 weeks | 2-4 month | |
| Control group | 92% | 94.5% | 80% |
| Tested group | 97% | 97% | 95% |
From table 1, the product in the present invention coordinates conventional therapy, the success rate for the treatment of can be significantly improved in long-term treatment,
Reduce the recurrence rate of disease.
The foregoing description of the disclosed embodiments, enables professional and technical personnel in the field to realize or uses the present invention.To these
Various modifications of embodiment will be apparent for those skilled in the art, generic principles defined herein
Can realize in other embodiments without departing from the spirit or scope of the present invention.Therefore, the present invention will not be by
It is limited to the embodiments shown herein, and is to fit to consistent with principles disclosed herein and features of novelty most wide
Scope.
Claims (5)
1. it is a kind of improve women's health problem solid beverage, it is characterised in that the following active component comprising following weight fraction：
Probiotic powder 30-35% and Cranberry extract 4-6%, also including the auxiliary material of following weight fraction：FOS 50%, xylitol
10-12%, microcrystalline cellulose 0.35%.
2. a kind of solid beverage for improving women's health problem according to claim 1, it is characterised in that solid drink
Following component comprising following weight fraction in material：Probiotic powder 33.3%, Cranberry extract 5%, FOS 50%, wood
Sugar alcohol 11.35%, microcrystalline cellulose 0.35%.
3. it is according to claim 1 it is a kind of improve women's health problem solid beverage, it is characterised in that the probiotics
The total content of Lactobacillus helveticus and Lactobacillus rhamnosus is 15,000,000,000 cfu/g in powder.
4. it is according to claim 1 it is a kind of improve women's health problem solid beverage, it is characterised in that the Cranberry
The weight fraction of extract procyanidins is 4%.
5. a kind of solid beverage for improving women's health problem according to claim 1, it is characterised in that solid drink
Material be by by the active component and auxiliary material it is well mixed after be packaged to be.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510822170.2A CN106721834A (en) | 2015-11-19 | 2015-11-19 | A kind of solid beverage for improving women's health problem |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510822170.2A CN106721834A (en) | 2015-11-19 | 2015-11-19 | A kind of solid beverage for improving women's health problem |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106721834A true CN106721834A (en) | 2017-05-31 |
Family
ID=58963422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510822170.2A Pending CN106721834A (en) | 2015-11-19 | 2015-11-19 | A kind of solid beverage for improving women's health problem |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106721834A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107647234A (en) * | 2017-08-25 | 2018-02-02 | 善恩康生物科技（苏州）有限公司 | A kind of Ms probiotics solid beverage |
| CN107668460A (en) * | 2017-10-27 | 2018-02-09 | 广西壮族自治区农业科学院农产品加工研究所 | A kind of selenium-enriched probioticses solid beverage and preparation method thereof |
| CN108157703A (en) * | 2018-02-01 | 2018-06-15 | 河北朗益生物科技有限公司 | A kind of Cranberry inulin probiotics solid beverage and preparation method thereof |
| CN108576802A (en) * | 2018-03-27 | 2018-09-28 | 维乐维健康产业有限公司 | A kind of composition of maintenance women's health |
| CN108902981A (en) * | 2018-04-25 | 2018-11-30 | 深圳市多微生保健食品有限公司 | A kind of probiotic composition and probiotics solid beverage |
| CN109432160A (en) * | 2018-12-12 | 2019-03-08 | 广州普维君健药业有限公司 | The probiotic composition and its preparation method and application for treating women vaginitis |
| CN111150059A (en) * | 2020-01-19 | 2020-05-15 | 西倍健生物科技(深圳)有限公司 | Special probiotic bacterium composition for women and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140294790A1 (en) * | 2008-01-11 | 2014-10-02 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Method of preventing, controlling and ameliorating urinary tract infections and supporting digestive health by using a synergistic cranberry derivative, a d-mannose composition and a proprietary probiotic blend |
-
2015
- 2015-11-19 CN CN201510822170.2A patent/CN106721834A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140294790A1 (en) * | 2008-01-11 | 2014-10-02 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Method of preventing, controlling and ameliorating urinary tract infections and supporting digestive health by using a synergistic cranberry derivative, a d-mannose composition and a proprietary probiotic blend |
Non-Patent Citations (4)
| Title |
|---|
| 加百列: "《如何选择营养素》", 30 June 2009, 中国社会出版社 * |
| 曾庆祝: "《食品安全与卫生》", 31 October 2012, 中国质检出版社 * |
| 梁朗都: "《食品添加剂在饮料中的应用》", 31 March 2005, 中国轻工业出版社 * |
| 海春旭: "《自由基医学》", 31 December 2006, 第四军医大学出版社 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107647234A (en) * | 2017-08-25 | 2018-02-02 | 善恩康生物科技（苏州）有限公司 | A kind of Ms probiotics solid beverage |
| CN107668460A (en) * | 2017-10-27 | 2018-02-09 | 广西壮族自治区农业科学院农产品加工研究所 | A kind of selenium-enriched probioticses solid beverage and preparation method thereof |
| CN108157703A (en) * | 2018-02-01 | 2018-06-15 | 河北朗益生物科技有限公司 | A kind of Cranberry inulin probiotics solid beverage and preparation method thereof |
| CN108576802A (en) * | 2018-03-27 | 2018-09-28 | 维乐维健康产业有限公司 | A kind of composition of maintenance women's health |
| CN108576802B (en) * | 2018-03-27 | 2021-11-16 | 仙乐健康科技(安徽)有限公司 | Composition for maintaining female health |
| CN108902981A (en) * | 2018-04-25 | 2018-11-30 | 深圳市多微生保健食品有限公司 | A kind of probiotic composition and probiotics solid beverage |
| CN109432160A (en) * | 2018-12-12 | 2019-03-08 | 广州普维君健药业有限公司 | The probiotic composition and its preparation method and application for treating women vaginitis |
| CN111150059A (en) * | 2020-01-19 | 2020-05-15 | 西倍健生物科技(深圳)有限公司 | Special probiotic bacterium composition for women and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106721834A (en) | A kind of solid beverage for improving women's health problem | |
| CN104830731B (en) | One strain has plant lactobacillus AB-1 and the application thereof of broad-spectrum antibacterial characteristic | |
| EP1539927B1 (en) | Probiotic bacterium: lactobacillus fermentum | |
| US20080102061A1 (en) | Use hydrolyzed medium containing microorganisms medicinally | |
| US8246946B2 (en) | Treatment of bipolar disorder utilizing anti-fungal compositions | |
| CN104508117B (en) | New Lactobacillus crispatus bacterial strain | |
| CN110016442A (en) | The application of Lactobacillus rhamnosus and its composite bacterium powder in prevention and treatment vaginitis product | |
| CN109464487A (en) | Probiotics compound of anti-helicobacter pylori and preparation method thereof | |
| KR20020019059A (en) | A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use | |
| KR20030082549A (en) | Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications | |
| CN103409334B (en) | Inhibit the Bacillus acidi lactici and application thereof of vaginitis pathogen | |
| CN105555284A (en) | Strain of lactobacillus pentosus as probiotic | |
| US11344587B2 (en) | Method of improving urogenital health using probiotic bacteria | |
| WO2005030230A1 (en) | Compositions and methods for treatment or prevention of psoriasis and related disorders | |
| Soares et al. | Sporeforming probiotic bacteria: Characteristics, health benefits, and technological aspects for their applications in foods and beverages | |
| CN107996936A (en) | A kind of solid beverage for improving stomach health problem | |
| ES2927070T3 (en) | Lactic acid bacterial composition for the treatment of Gardnerella vaginalis bacterial vaginal infections and, if present, concurrent fungal infections | |
| CN114287633B (en) | Probiotic composition containing cranberry and application thereof in helicobacter pylori resistance | |
| KR101833832B1 (en) | A composition comprising specific lactic acid bacteria for protecting and treating vaginosis disease and the use thereof | |
| KR101779719B1 (en) | Novel Lactobacillus kefiranofaciens DN1 and composition for treating or preventing constipation comprising the same | |
| CN109527308A (en) | A kind of probiotics drink and preparation method thereof with coordinating intestines and stomach function | |
| DE102017113263A1 (en) | Pharmaceutical composition containing bacterial strains of the family Lactobacillaceae and whey | |
| KR101577732B1 (en) | Pharmaceutical composition comprising ferment of Phellodendron amurensis as an active ingredient for prevention or treatment of metabolic bone disease or climacteric disease | |
| CN112007067A (en) | Privacy protecting probiotic compositions | |
| WO2020079641A1 (en) | Compositions comprising essential oils and/or hydrolates from plants of italian origin and the use thereof for the treatment of gastrointestinal and genitourinary disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |